Skip Main Navigation
Office of Management and Budget
President's Budget
Information &
Regulatory Affairs
Legislative Information
Agency Information

Meeting Record Regarding: Use of Ozone Depleting Substances Removal of Essential Use Designation

Date: 5/11/2004

Name Affiliation Client (if applicable)
Fumie Yokota OMB  
Matthew Vaeth OMB/Health Division  
Loren Monroe Barbour Griffith & Rogers, Inc. GlaxoSmithKline
Sally Walsh GlaxoSmithKline  
Emily Bishko National Economic Research Associates, Inc.  
Richard Rozek National Economic Research Associates, Inc.  
Dominic Mancini OMB  
Brenda Aguilar OMB  
John Morrall OMB  
Don Arbuckle OMB  
Robert Meyer FDA (by phone)  
Wayne Mitchell FDA (by phone)